Core Insights - The company reported a significant increase in revenue and net profit for Q3 2025, with revenue reaching CNY 1,150,985,938.17, a year-on-year growth of 19.59%, and net profit attributable to shareholders amounting to CNY 252,944,042.74, reflecting a 63.49% increase [3][4]. Financial Performance - For the first nine months of 2025, the company achieved a cumulative revenue of CNY 3,496,425,547.05, up 24.69% year-on-year, and a net profit of CNY 733,410,196.89, which is a 35.49% increase [3][4]. - The basic earnings per share (EPS) for Q3 2025 was CNY 0.39, a 69.57% increase compared to the same period last year, while diluted EPS was CNY 0.37, up 48.00% [3][4]. - The weighted average return on equity (ROE) was 7.91%, an increase of 3.65 percentage points from the previous year [4]. Research and Development - The company's R&D expenditure for Q3 2025 totaled CNY 212,588,897.62, representing a 47.02% increase year-on-year, and accounted for 18.47% of revenue, up 3.45 percentage points from the previous year [4]. Asset and Equity Growth - As of September 30, 2025, the total assets of the company were CNY 6,824,936,820.48, an 8.20% increase from the end of the previous year, while the equity attributable to shareholders was CNY 3,565,075,087.52, a slight increase of 0.20% [4]. Cash Flow Analysis - The net cash flow from operating activities for the first nine months of 2025 was CNY 202,110,558.48, which represents a significant decline of 55.75% year-on-year, primarily due to increased procurement and inventory costs associated with business growth [4].